The establishment of Institut Kanser Negara represents the realisation of the Malaysian Government’s aspiration to provide high-quality and safe healthcare services for all Malaysians, specifically in the treatment of solid organ cancers. The idea to establish the Institute was initiated by the late Tun Endon Mahmood, wife of the 5th Prime Minister of Malaysia, Tun Abdullah Haji Ahmad Badawi.
Institut Kanser Negara commenced operations on 2 September 2013, ahead of its official handover to the Ministry of Health Malaysia, which took place on 18 September 2013 during a formal Project Handover Ceremony. The institute is a hospital equipped with advanced medical equipment and the latest information technology. It encompasses diagnostic and specialized treatment services in addressing various types of cancer.
The main services provided at the Institut Kanser Negara include Radiotherapy & Oncology, Nuclear Medicine, Oncological Surgery, and Palliative Care. Other services offered include specialist outpatient clinics, inpatient care, day care treatment services, and clinical support services. Institut Kanser Negara aspires to become a centre of excellence in cancer treatment, research, education, and premier healthcare services in Malaysia.
To be the leading institution in cancer treatment, education, and research, with the aim of improving the quality of life for cancer patients and survivors.
• To provide the highest quality cancer treatment services for cancer patients.
• To serve as a centre for education and specialised training in cancer management and care for various categories of healthcare personnel, including specialists, medical officers, allied health scientists, and paramedics.
• To become a central hub and leading institution for cancer research in Malaysia, encompassing aspects of treatment and patient care, in collaboration with local and international agencies.
The establishment of the National Cancer Institute (IKN) fulfills the Malaysian government's aspiration to provide safe, high-quality healthcare services for the diagnosis and treatment of solid-organ cancers. The IKN project was implemented in two principal phases: Phase 1 comprised construction of PET-CT and cyclotron facilities, and Phase 2 comprised construction of the main IKN building. On 7 November 2006, the PET-CT and cyclotron facilities on the grounds of Putrajaya Hospital were completed; these facilities produce various radiopharmaceuticals for clinical use. Construction of the main IKN building began on 9 January 2007 and was completed on 16 August 2013. IKN commenced operations on 2 September 2013. The institute features a patient- and eco-friendly design, is equipped with advanced, modern technology, and provides diagnostic and cancer treatment services while integrating a Total Hospital Information System (THIS).
Key clinical services provided at the National Cancer Institute (Institut Kanser Negara):
These are the inpatient facilities available at the National Cancer Institute (IKN):
Specialist clinic services at the National Cancer Institute (IKN) are provided exclusively for cancer patients who have been referred through government or private hospitals. The clinics available at the National Cancer Institute include:
Day care treatment services are provided for cancer patients who require outpatient treatment without the need for hospital admission. Patients will receive treatment at the Oncology Day Care Clinic. The day care treatment services available include:
• Chemotherapy
• Blood transfusion
| Total Population | 34,200,000 | ||
|---|---|---|---|
| Income Group | Upper Middle | ||
| Total Deaths | 196,965 | ||
| Life Expectancy at birth | Total | 75 | |
| Male | 73 | ||
| Female | 77 | ||
| Cancer Mortality Profile |  |
||
| Age-Standardized Cancer Mortality Trends |  |
||
| Cancer Incidence |  |
||
| Adult Risk Factors | Current tobacco smoking (2011 Data) | Males | 43.1% |
| Females | 1.1% | ||
| Total | 22.6% | ||
| Total alcohol per capita consumption, in litres of pure alcohol (2010 Data) | Males | 2.5 | |
| Females | 0.2 | ||
| Total | 1.3 | ||
| Physical inactivity (2010 Data) | Males | 45.6% | |
| Females | 57.2% | ||
| Total | 51.6% | ||
| Obesity (2014 Data) | Males | 10.3% | |
| Females | 15.3% | ||
| Totals | 12.9% | ||
| Household solid fuel use (2012 Data) | Males | NA | |
| Females | NA | ||
| Total | 0% | ||
| Cancer Plans, Monitoring, and Surveillance | Has an operational cancer policy/strategy/action plan | Yes | |
| Has a cancer registry | |||
| Scope | Population-based | ||
| Coverage | National | ||
| Last Year of Data | 2021 | ||
| Cancer Primary Prevention Policies | Tobacco Control | Has an operational policy, strategy or action plan to reduce the burden of tobacco use | Yes |
| Smoke-free legislation | Up to two public places completely smoke-free | ||
| Tobacco dependence treatment | NRT and/or some cessation services (neither cost-covered) | ||
| Warning labels | Large warning with all appropriate characteristics* | ||
| Bans on advertising, promotion and sponsorship | Ban on national television, radio and print media as well as on some but not all other forms of direct and/or indirect advertising | ||
| Tobacco taxes | 51-75% of retail price is tax | ||
| Overweight and obesity prevention and control | Has an operational policy, strategy or action plan for reducing overweight/obesity | Yes | |
| Physical inactivity prevention and control | Has an operational policy, strategy or action plan to reduce physical inactivity and/or promote physical activity | Yes | |
| Harmful use of alcohol prevention and control | Has an operational policy, strategy or action plan to reduce the harmful use of alcohol | No | |
| National Immunization | Human Papillomavirus vaccination schedule | 13 years, +1 month, +6 months | |
| Hepatitis B vaccination schedule | Birth, +1 month, +6 months | ||
| Hepatitis B vaccination coverage, infants | 96% | ||
| Cancer Screening and Early Detection | Cervical Cancer | Cervical cytology (PAP) | Generally available at the public primary health care level |
| Acetic Acid Vizualization (VIA) | Not generally available at the public primary health care level | ||
| Breast Cancer | Breast palpation / clinical breast exam (CBE) | Generally available at the public primary health care level | |
| Mammogram | Generally available at the public primary health care level | ||
| Colorectal Cancer | Faecal occult blood test or faecal immunological test | Generally available at the public primary health care level | |
| Bowel cancer screening by exam or colonoscopy | Not generally available at the public primary health care level | ||
| Cancer Treatment and Palliative Care | Radiotherapy | Generally available in the public health system | |
| Total high energy teletherapy units / million inhabitants | 1 | ||
| Number of radiotherapy centres | 25 | ||
| Number of radiation oncologists | 6 | ||
| Chemotherapy (medicines not specified) | Generally available in the public health system | ||
| Oral morphine (formulation not specified) | Not generally available in the public health system | ||
| Non-methadone morphine equivalent consumption per cancer death (mg) | NA | ||
| Community/home care for people with advanced stage cancer and other NCDs | Generally available | ||
| REMARKS | * Indicates highest possible level of achievement | ||
| SOURCE | Extracted from: WHO Cancer Country Profiles 2014 (https://www.who.int/cancer/country-profiles/mys_en.pdf?ua=1) as of 2019/05/30 | ||
Please complete the form below to send us an E-Mail. For security and anti-spam purposes, we do not post our E-Mail addresses on our website.
.jpeg)
.jpeg)
